MobileODT helps clinicians utilize the power of AI on its portable medical devices to enhance womens health. MobileODTs EVA System combines advanced imaging, data and software applications to expand access to quality care in 30 countries and across more than 60 US health systems. The EVA Systems smart mobile colposcope is used by clinicians worldwide for colposcopy, general gynecology, telegynecology and forensic imaging. MobileODT is integrating its AI in approved markets to provide powerful clinical decision support to healthcare providers at the point-of-care. MobileODT is headquartered in Tel Aviv. The company has received investment capital from Orbimed, Tristel, Tara Health, Laerdal, DAI, and others.
Last Funding Series
Startup Profile Funding Rounds
AI Technology Stack
AI Team Size
AI clinical decision support for assessing cervical cancer: VisualCheck* provides clinicians with AI (Augmented Intelligence) clinical decision support technology to assess for normal and abnormal cervical findings. Using a complex algorithm, VisualCheck predicts how highly trained colposcopists determine findings of the cervix. The algorithm is trained on thousands of images of the cervix that top colposcopists in the US have annotated. EVA’s easy-to-use software enables easy patient data management, image and video capture, annotations, clinical decision-tracking, and easy data export for integration into electronic medical records. EVA’s innovative imaging algorithms and 16x optical magnification enable sharp visualization and high-quality vulvar and cervical image or video capture. Add annotations and filters to images: Use EVA´s image enhancement features such as annotations for biopsy location and a green filter for tissue differentiation to add crucial patient assessment information to aid diagnosis.